Janus Henderson Group PLC Atara Biotherapeutics, Inc. Transaction History

Janus Henderson Group PLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$2.8 - $5.46 $51,153 - $99,748	18,269 Added 125.48%	32,828 $95,000
Q3 2022 Nov 14, 2022	BUY	$2.85 - $8.73 $62 - $192	22 Added 0.15%	14,559 $55,000
Q2 2022 Aug 15, 2022	BUY	$4.69 - $9.84 $75 - $157	16 Added 0.11%	14,537 $113,000
Q1 2022 May 16, 2022	BUY	$8.44 - $16.89 $122,557 - $245,259	14,521 New	14,521 $135,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $728M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

Stay updated on Janus Henderson Group PLC with notifications on news.